General Information
Revision date
2019-07-01
Product name
Vemurafenib, Free Base
CAS No.
918504-65-1
Icons in SDS
Company Information
company name
LC Laboratories
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302+H312+H332
Hazard statements
Code
Statements
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
Hazard statements
Harmful; pharmaceutically active substance Causes phototoxicity (skin irritation resulting from exposure to light) May cause skin cancer Ingestion may cause arthralgia (joint pain), rash, pruritus (itch), fatigue, headache, nausea, anorexia (decreased appetite), diarrhea, alopecia (hair loss), folliculitis (inflammation of hair follicles), keratoacanthoma (hair follicle skin tumor), cutaneous squamous cell carcinoma, photosensitivity, hypersensitivity, Stevens-Johnson syndrome and toxic epidermal necrolysis (two life-threatening skin conditions in which cell death causes the epidermis to separate from the dermis), uveitis (inflammation of the middle layer of the eye), QT prolongation (abnormal heart rate), serious hypersensitivity reactions including anaphylaxis (immune system disorder), and hepatotoxicity causing liver damage) H302+312+332 - Harmful if swallowed, in contact with skin or if inhaled
Precautionary statements
P2562 - Do not get in eyes, on skin or on clothing WARNING For Laboratory Research Use Only
